Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Molecular imaging techniques have rapidly progressed over recent decades providing unprecedented in vivo characterization of metabolic pathways and molecular biomarkers. Many of these new techniques have been successfully applied in the field of neuro-oncological imaging to probe tumor biology. Targeting specific signaling or metabolic pathways could help to address several unmet clinical needs that hamper the management of patients with brain tumors. This review aims to provide an overview of the recent advances in brain tumor imaging using molecular targeting with positron emission tomography and magnetic resonance imaging, as well as the role in patient management and possible therapeutic implications.

Original publication

DOI

10.1016/j.ejrad.2021.109842

Type

Journal article

Journal

Eur J Radiol

Publication Date

09/2021

Volume

142

Keywords

Brain tumor, Glioma, MRI, Molecular imaging, PET, Theranostics, Brain Neoplasms, Humans, Magnetic Resonance Imaging, Molecular Targeted Therapy, Positron-Emission Tomography, Tomography, X-Ray Computed